IL-4-induced apoptosis in peripheral blood eosinophils

Journal of Allergy and Clinical Immunology

Volumn 102, Issue 6 II, 1998, Pages 1013-1020

  Wedi, Bettina ^a   Raap, Ulrike ^a   Lewrick, Heitje ^a   Kapp, Alexander ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Apoptosis; Eosinophils; Fas antigen; IL 4

Indexed keywords

CYTOKINE; DEXAMETHASONE; FAS ANTIGEN; HYDROCORTISONE; INTERLEUKIN 1BETA; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 5; INTERLEUKIN 8; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; STEROID; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; ATOPIC DERMATITIS; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0032433670     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(98)70340-9     Document Type: Article

References (49)

1. Baggiolini M, Dahinden CA. CC chemokines in allergic inflammation. Immunol Today 1994;15:127-33.
2. Schröder JM, Noso N, Sticherling M, Christophers E. Role of eosinophilchemotactic C-C chemokines in cutaneous inflammation. J Leukoc Biol 1996;59:1-5.
3. Faccioli LH, Nourshargh S, Moqbel R, Williams FM, Sehmi R, Kay AB, et al. The accumulation of 111 In-eosinophils induced by inflammatory mediators, in vivo. Immunology 1991;73:222-7.
4. Sanz MJ, Weg VB, Bolanowski MA, Nourshargh S. IL-1 is a potent inducer of eosinophil accumulation in rat skin: inhibition of response by a platelet-activating factor antagonist and an anti-human IL-8 antibody. J Immunol 1995;154:1364-73.
5. Rodgers S, Rees RC, Hancock BW Changes in the phenotypic characteristics of eosinophils from patients receiving recombinant human interleukin-2 (rhIL-2) therapy. Br J Haematol 1994;86:746-53.
6. Hamid Q, Naseer T, Minshall EM, Song YL, Boguniewicz M, Leung DYM. In vivo expression of IL-12 and IL-13 in atopic dermatitis. J Allergy Clin Immunol 1996;98:225-31.
7. Stern M, Meagher L, Savill J, Haslett C. Apoptosis in human eosinophils: programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5. J Immunol 1992;148:3543-9.
8. Simon H, Blaser K. Inhibition of programmed eosinophil death: a key pathogenic event for eosinophilia? Immunol Today 1995;16:53-5.
9. Tai PC, Sun L, Spry CJ. Effects of IL-5, granulocyte/macrophage colony-stimulating factor (GM-CSF) and IL-3 on the survival of human blood eosinophils in vitro. Clin Exp Immunol 1991;85:312-6.
10. Yamaguchi Y, Suda T, Ohta S, Tominaga K, Miura Y, Kasahara T. Analysis of the survival of mature human eosinophils: interleukin-5 prevents apoptosis in mature human eosinophils. Blood 1991;78:2542-7.
11. Rothenberg ME, Owen WFJ, Silberstein DS, Woods J, Soberman RJ, Austen KF, et al. Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin-3. J Clin Invest 1988;81:1986-92.
12. Alam R, Forsythe P, Stafford S, Fukuda Y Transforming growth factor beta abrogates the effects of hematopoietins on eosinophils and induces their apoptosis. J Exp Med 1994;179:1041-5.
13. Druilhe A, Cai Z, Haile S, Chouaib S, Pretolani M. Fas-mediated apoptosis in cultured human eosinophils. Blood 1996;87:2822-30.
14. Wallen N, Kita H, Weiler D, Gleich GJ. Glucocorticoids inhibit cytokinemediated eosinophil survival. J Immunol 1991;147:3490-5.
15. Cox G. Glucocorticoid treatment inhibits apoptosis in human neutrophils. J Immunol 1995;154:4719-25.
16. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1980;92:44-7.
17. Zeck-Kapp G, Kroegel C, Riede UN, Kapp A. Mechanisms of human eosinophil activation by complement protein C5a and platelet-activating factor: similar functional responses are accompanied by different morphologic alterations. Allergy 1995;50:34-47.
18. Elsner J, Oppermann M, Czech W, Dobos G, Schopf E, Norgauer J, et al. C3a activates reactive oxygen radical species production and intracellular calcium transients in human eosinophils. Eur J Immunol 1994;24:518-22.
19. Leist M, Gantner F, Bohlinger I, Germann PG, Tiegs G, Wendel A. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest. J Immunol 1994;153:1778-88.
20. Wedi B, Elsner J, Czech W, Butterfield JH, Kapp A. Modulation of inter-cellular adhesion molecule 1 (ICAM-1) expression on the human mast-cell line (HMC)-1 by inflammatory mediators. Allergy 1996;51:676-84.
21. Maly FE, Urwyler A, Rolli HP, Dahinden CA, De Weck AL. A single-photon imaging system for the simultaneous quanti tation of luminescent emissions from multiple samples. Anal Biochem 1988;168:462-9.
22. Wedi B, Raap U, Lewrick H, Kapp A. Delayed eosinophil programmed cell death: a common feature of inhalant allergy and extrinsic and intrinsic atopic dermatitis. J Allergy Clin Immunol 1997;100:1-7.
23. Matsumoto K, Schleimer RP, Saito H, Iikura Y, Bochner BS. Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. Blood 1995;86:1437-43.
24. Sehmi R, Cromwell O, Wardlaw AJ, Moqbel R, Kay AB. Interleukin-8 is a chemoattractant for eosinophils purified from subjects with a blood eosinophilia but not from normal healthy subjects. Clin Exp Allergy 1993;23:1027-36.
25. Warringa RA, Mengelers HJ, Kuijper PH, Raaijmakers JA, Bruijnzeel PLB, Koenderman L. In vivo priming of platelet-activating factor-induced eosinophil chemotaxis in allergic asthmatic individuals. Blood 1992;79:1836-41.
26. Ochiai K, Kagami M, Matsumura R, Tomioka H. IL-5 but not interferon-gamma (IFN-gamma) inhibits eosinophil apoptosis by up-regulation of bcl-2 expression. Clin Exp Immunol 1997;107:198-204.
27. Mangan DE, Robertson B, Wahl SM. IL-4 enhances programmed cell death (apoptosis) in stimulated human monocytes. J Immunol 1992;148:1812-6.
28. Dubois GR, Bruijnzeel-Koomen CA, Bruijnzeel PL. IL-4 induces chemotaxis of blood eosinophils from atopic dermatitis patients, but not from normal individuals. J Invest Dermatol 1994;102:843-6.
29. Terada N, Konno A, Terada Y, Fukuda S, Yamashita T, Abe T, et al. IL-4 upregulates FcεRI α-chain messenger RNA in eosinophils. J Allergy Clin Immunol 1995;96:1161-9.
30. Bratton DL, Hamid Q, Boguniewicz M, Doherty DE, Kailey JM, Leung DYM. Granulocyte macrophage colony-stimulating factor contributes to enhanced monocyte survival in chronic atopic dermatitis. J Clin Invest 1995;95:211-8.
31. Girard D, Paquin R, Beaulieu AD. Responsiveness of human neutrophils to interleukin-4: induction of cytoskeletal rearrangements, de novo protein synthesis and delay of apoptosis. Biochem J 1997;325:147-53.
32. Hebestreit H, Yousefi S, Balatti I, Weber M, Crameri R, Simon D, et al. Expression and function of the Fas receptor on human blood and tissue eosinophils. Eur J Immunol 1996;26:1775-80.
33. Valent P. The phenotype of human eosinophils, basophils, and mast cells. J Allergy Clin Immunol 1994;94:1177-83.
34. Ishii N, Takeshita T, Kimura Y, Tada K, Kondo M, Nakamura M, et al. Expression of the IL-2 receptor gamma chain on various populations in human peripheral blood. Int Immunol 1994;6:1273-7.
35. Schleimer RP, Sterbinsky SA, Kaiser J, Bickel CA, Klunk DA, Tomioka K, et al. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium: association with expression of VCAM-1. J Immunol 1992;148:1986-92.
36. Baskar P, Silberstein DS, Pincus SH. Inhibition of IgG-triggered human eosinophil function by IL-4. J Immunol 1990;144:2321-6.
37. Tepper RI. The eosinophil-mediated antitumor activity of interleukin-4. J Allergy Clin Immunol 1994;94:1225-31.
38. Elsner J, Hochstetter R, Spiekermann K, Kapp A. Surface and mRNA expression of the CD52 antigen by human eosinophils but not by neutrophils. Blood 1996;88:4684-93.
39. Horie S, Gleich GJ, Kita H. Cytokines directly induce degranulation and Superoxide production from human eosinophils. J Allergy Clin Immunol 1996;98:371-81.
40. Chan SC, Brown MA, Willcox TM, Li SH, Stevens SR, Tara D, et al. Abnormal IL-4 gene expression by atopic dermatitis T lymphocytes is reflected in altered nuclear protein interactions with IL-4 transcriptional regulatory element. J Invest Dermatol 1996;106:1131-6.
41. Walker C, Bauer W, Braun RK, Menz G, Braun P, Schwarz F, et al. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am J Respir Crit Care Med 1994;150:1038-48.
42. Renz H, Jujo K, Bradley KL, Domenico J, Gelfand EW, Leung DYM. Enhanced IL-4 production and IL-4 receptor expression in atopic dermatitis and their modulation by interferon-gamma. J Invest Dermatol 1992;99:403-8.
43. Sager N, Feldmann A, Schilling G, Kreitsch P, Neumann C. House dust mite-specific T cells in the skin of subjects with atopic dermatitis: frequency and lymphokine profile in allergen patch test. J Allergy Clin Immunol 1992;89:801-10.
44. Schrier DJ, Schimmer RC, Flory CM, Tung DK-L, Ward PA. Role of chemokines and cytokines in a reactivation model of arthritis in rats induced by injection with streptococcal cell walls. J Leukoc Biol 1998;63:359-63.
45. Borish L, Rosenwasser LJ. Update on cytokines. J Allergy Clin Immunol 1996;97:719-34.
46. Hamid Q, Boguniewicz M, Leung DYM. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 1994;94:870-5.
47. Nonaka M, Nonaka R, Woolley K, Adelroth E, Miura K, Okhawara Y, et al. Distinct immunohistochemical localization of IL-4 in human inflamed airway tissues. IL-4 is localized to eosinophils in vivo and is released by peripheral blood eosinophils. J Immunol 1995;155:3234-44.
48. Walker C, Bode E, Boer L, Hansel TT, Blaser K, Virchow JC. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 1992;146:109-15.
49. Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, et al. Eosinophilic inflammation in asthma [see comments], N Engl J Med 1990;323:1033-9.